Mielopid

Roman name

Myelopidum

The composition and the form of

The preparation of Nature peptide derived from the extraction cell culture bone marrow mammals

Of drugs

In immunodeficiency states (decrease or absence of defence organism) product restores the structural and T-sistem immunity stimulates production of antibodies (proteins blood formed in response to falling into alien organism proteins and toxins) and the functional activity of immunocompetent cells and the rebuilding is other indicators point gumoralland immunity (woven senior defence organism).

Storage conditions

List B. In the dark place at a temperature from 4 to 6 ° C.

Shelf life

por.d / in. : 2 grams.

Indications for use

Mielopid applied in adults with secondary immunodeficiency states favouring defeat gumoralland officials immunity, including for the prevention of infectious complications after surgical interventions, injuries, osteomyelitis (inflammation of bone marrow and adjacent bone), and other pathological processes involving inflammatory complications, as well as for the treatment of complications of nonspecific lung diseases chronic piodermiah (gnanom nerve skin), etc. The mielopida is part of a comprehensive treatment of the disease.

Dosing and Administration

Mielopid misleading under the skin of 0,003-0,006 grams (3-6 mg) daily or every other day; In the course -3-5 injection. Duration of treatment and the total dose depend on the clinical results and the immune status (of the defence organism).

Side-Effects

In applying mielopida possible dizziness, weakness, nausea, hyperemia (redness) and soreness at the site of introduction, the body temperature.

Contraindications

The drug is contraindicated for pregnant with rezusconflikta (not pregnant rhesus and fruit).

Form of

Liofilizirovanny (Dewatered by freezing in a vacuum) powder in hermetically ukuporennah bottle capacity 10 ml containing 0,003 grams (3 mg).

Directory → Immunotropona funds → Immunomodulators → Mielopid